Primary care IBS patients often carry a heavier symptom and psychosocial burden than expected
Primary care remains the main entry point for patients with irritable bowel syndrome, yet the clinical profile of those patients has been described far less often than the profiles seen in specialty clinics. A post hoc analysis of the DOMINO study begins to close that gap by examining 483 adults who received a new IBS diagnosis from primary care physicians. The message from these baseline data is blunt: many patients arriving in routine care already meet formal diagnostic criteria, and many are carrying a symptom load that is well beyond mild.
Among the primary care cohort, 70% fulfilled the Rome IV criteria. Stool pattern subtypes were distributed as 20% constipation-predominant IBS, 33% diarrhea-predominant IBS, 31% mixed IBS, and 16% unclassified IBS. In practical terms, diarrhea and mixed bowel habits accounted for nearly two-thirds of the group. That pattern matters because subtype is not a cosmetic label; it influences diagnostic confidence, symptom interpretation, and the therapeutic conversation that follows the first visit.
The average IBS Symptom Severity Score was 268 ± 98, with 46% of patients falling into the moderate range and 36% into the severe range. A score distribution like this places a large share of patients in the zone where symptoms are already interfering with daily life, sleep, work, and social functioning. Primary care clinicians often see IBS early, but these data show that many patients are not presenting with a barely perceptible functional bowel disorder. They are presenting with sustained symptom burden.
Rome IV-positive patients showed worse symptoms, poorer quality of life, and more psychosocial strain
The comparison between Rome-positive and Rome-negative patients sharpened the clinical picture. Those who met Rome IV criteria had significantly higher IBS symptom severity, lower quality of life, and greater psychosocial comorbidity than those who did not. The direction of this association is biologically plausible. Rome IV is not just a questionnaire threshold; it identifies a cohort more likely to have a stable disorder of gut-brain interaction, where visceral hypersensitivity, altered motility, symptom vigilance, and psychological distress reinforce one another.
The quality-of-life signal is especially important in primary care, where IBS is often managed alongside work stress, sleep disruption, food avoidance, and uncertainty about whether symptoms are “serious enough” to pursue further evaluation. Lower IBS-QoL scores in the Rome-positive group suggest that the diagnostic label corresponds to more than symptom frequency alone. It maps onto a broader clinical burden that can shape adherence, health care use, and patient satisfaction with care.
One sentence captures the clinical imbalance clearly: most patients already met Rome IV criteria at the point of primary care diagnosis.
IBS-M carried the highest psychosocial burden among the subtypes
Subtype analysis added another layer. Patients with IBS-M, IBS-D, and IBS-C all scored significantly higher on IBS-SSS and IBS-QoL than the IBS-U group. Among these subtypes, IBS-M stood out further. Participants with mixed bowel habits had significantly higher somatic symptom disorder scores, depression scores, and anxiety scores compared with IBS-U.
This finding is clinically intuitive and potentially important at the bedside. Mixed bowel habits can create a moving target for both patients and physicians, because constipation and diarrhea may alternate without a stable pattern that feels easy to name or treat. That uncertainty can amplify symptom monitoring, increase worry about food or medications, and feed a cycle of bodily hypervigilance. The association with higher depression and anxiety scores suggests that IBS-M may be the subtype in which symptom instability and psychosocial burden are most tightly intertwined.
The data do not prove causality. They do, however, reinforce a familiar clinical reality: bowel pattern alone does not capture the full severity of IBS. Two patients can look similar on paper and differ sharply in quality of life, emotional burden, and the extent to which symptoms dominate daily routines. In this cohort, IBS-M patients were more burdened than the unclassified group, and their psychosocial profile was worse than would be expected from bowel symptoms alone.
What primary care should take from the DOMINO baseline profile
The strongest practical lesson from this analysis is not that IBS is common in primary care. That is already well known. The more useful point is that many newly diagnosed patients already meet formal Rome IV criteria and many already have moderate or severe symptom scores at baseline. For clinicians, this argues for a careful first assessment that goes beyond checking whether abdominal pain and altered bowel habits are present. Symptom severity, stool pattern, quality of life, and psychosocial burden should be assessed together.
A primary care model that treats IBS as a simple exclusion diagnosis risks missing the patients who are most burdened and most likely to need structured follow-up. Patients with Rome-positive IBS and especially those with IBS-M may merit closer attention to anxiety, depression, and somatic symptom burden, because these factors can shape symptom persistence and perceived treatment failure. In daily practice, that may influence whether reassurance alone is enough, whether dietary counseling should be paired with psychological support, and whether follow-up needs to be scheduled rather than left open-ended.
The study’s design also sets limits on interpretation. It is a cross-sectional post hoc analysis, so it describes baseline characteristics rather than treatment response or long-term outcome. The cohort came from newly diagnosed adults in primary care, which strengthens the relevance of the findings for front-line practice, but it does not answer whether these symptom and psychosocial patterns predict later healthcare use, response to therapy, or progression of symptoms over time. Those remain the clinically useful questions for the next phase of research.
For now, the DOMINO data make one point difficult to ignore: primary care IBS is frequently Rome IV-positive, commonly diarrhea-predominant or mixed, and often accompanied by a substantial psychosocial burden. The patients clinicians see first are not necessarily the mildest cases; many are already living with moderate to severe disease at diagnosis.